Mira Pharmaceuticalsincis A Clinical Stage Pharmaceutical Development Company Based In Miamifloridafounded In 2020Mira Focuses On Developing Treatments For Neurologic And Neuropsychiatric Disordersthe Company Went Public On August 32023And Operates Within The Drug Manufacturing Sector Of The Healthcare Industry Mira S Primary Products Are Ketamir 2An Oral Ketamine Analog Aimed At Treating Neuropathic Paintreatment Resistant Depressionmajor Depressive Disorder With Suicidal Ideationand Post Traumatic Stress Disorderand Mira 55An Oral Pharmaceutical Marijuana Analog Targeting Anxiety And Cognitive Decline In Early Stage Dementiaboth Candidates Are Designed To Enhance Bioavailability And Patient Complianceand They Have Been Classified By The Dea As Non Controlled Substanceswhich Streamlines Their Regulatory Processmira Holds Exclusive Rights To These Compounds In The U S Canadaand Mexicopositioning Itself As An Emerging Player In Neuroscience Innovation
No conferences found for this company.
| Company Name | Mira Scientific India |
| Country |
India
|
| Address | N/A |
| Telephone | N/A |
| N/A |
